DaVita Q1 2026 Earnings EPS Surges Past Estimates by 226 Yet Stock Barely Moves GRNT Q1 2026 Earnings EPS Misses Estimates by Over 80 GLBS Q4 2025 Earnings Strong EPS Surprise Driven by Operational Efficiency KAPA Q1 2026 Earnings EPS Misses Estimates as Development Expenses Weigh DFDV Q1 2026 Earnings EPS Miss and Stock Decline Reflect Ongoing Development Phase Phibro Animal Health PAHC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Beat